SANOFI-ADR (SNY) Fundamental Analysis & Valuation

NASDAQ:SNY • US80105N1054

Current stock price

47.54 USD
-0.45 (-0.94%)
Last:

This SNY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. SNY Profitability Analysis

1.1 Basic Checks

  • SNY had positive earnings in the past year.
  • In the past year SNY had a positive cash flow from operations.
  • In the past 5 years SNY has always been profitable.
  • Each year in the past 5 years SNY had a positive operating cash flow.
SNY Yearly Net Income VS EBIT VS OCF VS FCFSNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • SNY has a better Return On Assets (9.85%) than 91.10% of its industry peers.
  • SNY has a better Return On Equity (17.49%) than 89.53% of its industry peers.
  • SNY has a Return On Invested Capital of 13.76%. This is amongst the best in the industry. SNY outperforms 93.19% of its industry peers.
  • SNY had an Average Return On Invested Capital over the past 3 years of 7.41%. This is significantly below the industry average of 13.11%.
  • The last Return On Invested Capital (13.76%) for SNY is above the 3 year average (7.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.85%
ROE 17.49%
ROIC 13.76%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SNY Yearly ROA, ROE, ROICSNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 17.71%, SNY belongs to the best of the industry, outperforming 91.10% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SNY has declined.
  • SNY has a better Operating Margin (23.28%) than 90.58% of its industry peers.
  • SNY's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 72.55%, SNY is in the better half of the industry, outperforming 79.58% of the companies in the same industry.
  • SNY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.28%
PM (TTM) 17.71%
GM 72.55%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SNY Yearly Profit, Operating, Gross MarginsSNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. SNY Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SNY is creating value.
  • Compared to 1 year ago, SNY has less shares outstanding
  • The number of shares outstanding for SNY has been reduced compared to 5 years ago.
  • SNY has a worse debt/assets ratio than last year.
SNY Yearly Shares OutstandingSNY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
SNY Yearly Total Debt VS Total AssetsSNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • The Debt to FCF ratio of SNY is 1.86, which is an excellent value as it means it would take SNY, only 1.86 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 1.86, SNY belongs to the best of the industry, outperforming 94.24% of the companies in the same industry.
  • SNY has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
  • SNY has a Debt to Equity ratio of 0.22. This is in the lower half of the industry: SNY underperforms 60.21% of its industry peers.
  • Although SNY's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.86
Altman-Z N/A
ROIC/WACC1.85
WACC7.44%
SNY Yearly LT Debt VS Equity VS FCFSNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • SNY has a Current Ratio of 1.09. This is a normal value and indicates that SNY is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.09, SNY is doing worse than 84.82% of the companies in the same industry.
  • A Quick Ratio of 1.09 indicates that SNY should not have too much problems paying its short term obligations.
  • SNY's Quick ratio of 1.09 is on the low side compared to the rest of the industry. SNY is outperformed by 79.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
SNY Yearly Current Assets VS Current LiabilitesSNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SNY Growth Analysis

3.1 Past

  • SNY shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.82%.
  • Measured over the past 5 years, SNY shows a small growth in Earnings Per Share. The EPS has been growing by 5.58% on average per year.
  • Looking at the last year, SNY shows a small growth in Revenue. The Revenue has grown by 5.29% in the last year.
  • Measured over the past years, SNY shows a small growth in Revenue. The Revenue has been growing by 4.57% on average per year.
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%

3.2 Future

  • SNY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.49% yearly.
  • The Revenue is expected to grow by 5.29% on average over the next years.
EPS Next Y9.55%
EPS Next 2Y7.78%
EPS Next 3Y8.98%
EPS Next 5Y8.49%
Revenue Next Year7.06%
Revenue Next 2Y6.58%
Revenue Next 3Y6.1%
Revenue Next 5Y5.29%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SNY Yearly Revenue VS EstimatesSNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SNY Yearly EPS VS EstimatesSNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

7

4. SNY Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.20, the valuation of SNY can be described as reasonable.
  • Based on the Price/Earnings ratio, SNY is valued cheaply inside the industry as 92.15% of the companies are valued more expensively.
  • SNY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.95.
  • The Price/Forward Earnings ratio is 9.31, which indicates a very decent valuation of SNY.
  • Based on the Price/Forward Earnings ratio, SNY is valued cheaply inside the industry as 89.01% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 38.68. SNY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.2
Fwd PE 9.31
SNY Price Earnings VS Forward Price EarningsSNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, SNY is valued cheaply inside the industry as 94.24% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.91
EV/EBITDA N/A
SNY Per share dataSNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • SNY has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.07
PEG (5Y)1.83
EPS Next 2Y7.78%
EPS Next 3Y8.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. SNY Dividend Analysis

5.1 Amount

  • SNY has a Yearly Dividend Yield of 5.10%, which is a nice return.
  • SNY's Dividend Yield is rather good when compared to the industry average which is at 0.68. SNY pays more dividend than 97.38% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, SNY pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.1%

5.2 History

  • The dividend of SNY has a limited annual growth rate of 4.30%.
  • SNY has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of SNY decreased in the last 3 years.
Dividend Growth(5Y)4.3%
Div Incr Years2
Div Non Decr Years2
SNY Yearly Dividends per shareSNY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • SNY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y7.78%
EPS Next 3Y8.98%
SNY Yearly Income VS Free CF VS DividendSNY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

Find the best dividend stocksShow peers with best dividend

SNY Fundamentals: All Metrics, Ratios and Statistics

SANOFI-ADR

NASDAQ:SNY (4/21/2026, 11:24:05 AM)

47.54

-0.45 (-0.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.54%
Inst Owner Change-0.03%
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap114.39B
Revenue(TTM)70.49B
Net Income(TTM)12.49B
Analysts76
Price Target57.44 (20.82%)
Short Float %0.35%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 5.1%
Yearly Dividend2.26
Dividend Growth(5Y)4.3%
DPN/A
Div Incr Years2
Div Non Decr Years2
Ex-Date05-04
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.22%
Min EPS beat(2)4.58%
Max EPS beat(2)5.86%
EPS beat(4)3
Avg EPS beat(4)3.54%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)6
Avg EPS beat(8)4.07%
EPS beat(12)8
Avg EPS beat(12)3.12%
EPS beat(16)11
Avg EPS beat(16)3.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-2.08%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-0.61%
Revenue beat(12)2
Avg Revenue beat(12)-1.44%
Revenue beat(16)6
Avg Revenue beat(16)14.04%
PT rev (1m)-0.13%
PT rev (3m)-1.78%
EPS NQ rev (1m)1.45%
EPS NQ rev (3m)5.94%
EPS NY rev (1m)1.42%
EPS NY rev (3m)1.85%
Revenue NQ rev (1m)3.55%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE 10.2
Fwd PE 9.31
P/S 1.38
P/FCF 8.91
P/OCF 8.91
P/B 1.36
P/tB 25.5
EV/EBITDA N/A
EPS(TTM)4.66
EY9.8%
EPS(NY)5.11
Fwd EY10.74%
FCF(TTM)5.34
FCFY11.22%
OCF(TTM)5.34
OCFY11.22%
SpS34.45
BVpS34.89
TBVpS1.86
PEG (NY)1.07
PEG (5Y)1.83
Graham Number60.4789 (27.22%)
Profitability
Industry RankSector Rank
ROA 9.85%
ROE 17.49%
ROCE 16.67%
ROIC 13.76%
ROICexc 14.92%
ROICexgc 58.3%
OM 23.28%
PM (TTM) 17.71%
GM 72.55%
FCFM 15.49%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.86
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 87.43%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z N/A
F-Score5
WACC7.44%
ROIC/WACC1.85
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
EPS Next Y9.55%
EPS Next 2Y7.78%
EPS Next 3Y8.98%
EPS Next 5Y8.49%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%
Revenue Next Year7.06%
Revenue Next 2Y6.58%
Revenue Next 3Y6.1%
Revenue Next 5Y5.29%
EBIT growth 1Y7.73%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year31.64%
EBIT Next 3Y15.57%
EBIT Next 5Y9.74%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI-ADR / SNY Fundamental Analysis FAQ

What is the fundamental rating for SNY stock?

ChartMill assigns a fundamental rating of 6 / 10 to SNY.


Can you provide the valuation status for SANOFI-ADR?

ChartMill assigns a valuation rating of 7 / 10 to SANOFI-ADR (SNY). This can be considered as Undervalued.


Can you provide the profitability details for SANOFI-ADR?

SANOFI-ADR (SNY) has a profitability rating of 8 / 10.


Can you provide the financial health for SNY stock?

The financial health rating of SANOFI-ADR (SNY) is 5 / 10.